GMP Inspections Focus On Cleaning Issues; Warning Letters Trend Downward
This article was originally published in The Tan Sheet
FDA inspectors continue to focus on drug manufacturing equipment and facility cleaning practices, an analysis of GMP warning letters shows
You may also be interested in...
The Center for Drug Evaluation & Research will begin reviewing GMP warning letters March 1 as part of FDA's initiative to create a risk-based approach to pharmaceutical manufacturing
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Perrigo promotes in pricing, planning